INTRODUCTION
From health to life-threatening conditions such as septic shock, nitric oxide (NO⅐) regulates blood pressure [1] [2] [3] [4] , inflammation [4 -7] , and gene expression [8 -11] . Under homeostatic conditions, endothelial NO⅐ synthase (eNOS) continuously releases NO⅐, which diffuses into the underlying smooth muscle [12, 13] . Here, NO⅐ activates soluble guanylate cyclase and dilates the vasculature through the second messenger cyclic guanosine 5Ј-monophosphate (cGMP). Simultaneously, outward-diffusing NO⅐ protects the endothelium from injury and further supports microvascular blood flow by scavenging superoxide, thereby inhibiting neutrophil adhesion [14 -16] .
During septic shock, eNOS is down-regulated in the endothelium, and an inducible NO⅐ synthase (iNOS) isoform is expressed in vascular smooth muscle, greatly increasing NO⅐ output [17] [18] [19] [20] [21] . For a local nidus of infection, this response may help ensure the adequate delivery of neutrophils to the affected site. Vascular dilation increases leukocyte flow to the involved tissue. As NO⅐ acts over short distances, moving NO⅐ production deeper into the vessel wall might permit enhanced production without undue interference with leukocyte attachment to the endothelium [22] , an essential step in migration [23] . Furthermore, exposure of leukocytes to high concentrations of NO⅐, as encountered while traversing inflamed vessels, has been shown to boost the production of cytokines such as interleukin-8 (IL-8) [22, 24] and tumor necrosis factor ␣ (TNF-␣) [6, 7, [25] [26] [27] , thus reinforcing a strong, chemotactic gradient. Although potentially beneficial in a localized infection, these responses may be harmful in overwhelming, systemic infections and contribute to refractory hypotension, tissue damage, and death [3, 4, 13, 21] . It is important that noninfectious conditions such as reperfusion injury [28, 29] and atherosclerosis [30] have also been linked to similar maladaptive responses that result in leukocyte-mediated injury. This has led to investigations to better understand the underlying mechanisms by which NO⅐ regulates inflammation and gene expression.
IL-8 is a potent C-X-C chemokine that plays a pivotal role in innate immunity [31, 32] . As the primary, endogenous chemoattractant of neutrophils, IL-8 regulates essential host defenses in the early stages of microbial invasion. However, IL-8 is also thought to contribute to neutrophil-mediated tissue injury and organ failure in conditions such as the acute respiratory distress syndrome, reperfusion injury, and septic shock [32] [33] [34] . Similar to the effects of NO⅐ on neutrophil adhesion [14] and TNF-␣ [6, 7, 35, 36] , NO⅐ up-regulation of IL-8 appears to be cGMP-independent [22] . The TNF-␣ promoter is activated by NO⅐ through reduced binding of Sp protein to a cyclic adenosine monophosphate (cAMP)-sensitive, GC-box repressor element [36 -38] . Although NO⅐ has been shown to increase IL-8 protein and mRNA levels in lipopolysaccharide (LPS)-stimulated human neutrophils [22] and to transcriptionally up-regulate IL-8 in other cell types [39 -41] , NO⅐ regulation of IL-8 is incompletely understood. The IL-8 promoter lacks known GC box and cAMP-response elements [22, [42] [43] [44] , suggesting a regulatory pathway divergent from that of TNF-␣. Notably, IL-8 and TNF-␣ mRNA harbor AU-rich elements (ARE; AUUUA) in 3Ј-untranslated regions (3Ј-UTR), which subject them to post-transcriptional regulation [45] [46] [47] [48] [49] [50] . Further, a recent report in human pancreatic adenocarcinoma cells has found that NO⅐ regulation of IL-8 may be, in part, post-transcriptional [41] . It is important that p38 mitogenactivated protein kinase (MAPK) activation has been associated with the ability of LPS to regulate IL-8 mRNA stability [47] [48] [49] . We [51] and others [24] have found that NO⅐ activates p38 MAPK in U937 cells, and p38 MAPK inhibition has been shown to decrease NO⅐-induced IL-8 production in these cells [24] .
In the current investigation, we sought to comprehensively examine NO⅐ regulation of IL-8 in LPS-stimulated THP-1 cells. These cells were chosen as a reproducible, LPS-responsive, human cellular model that has been evaluated extensively in studies of post-transcription regulation [49] . Further, we wanted to approach this question in a system that was different from our previous studies in phorbol ester-differentiated U937 cells [35] [36] [37] [38] . Several key experiments were also performed in human primary monoctyes to investigate the biological relevance of results obtained with THP-1 cells. Specific goals were to directly compare the cyclic nucleotide dependence of IL-8 and TNF-␣ gene regulation; test effects of NO⅐ on IL-8 and TNF-␣ mRNA kinetics, transcription, and stability; investigate the IL-8 promoter for NO⅐-induced changes in activity and transcription factor binding; and finally, examine the role, if any, of p38 MAPK in the regulation of IL-8 by NO⅐.
MATERIALS AND METHODS

Reagents and cell cultures
Salmonella minnesota Re595 LPS was obtained from List Biologic (Campbell, CA). Dibutyryl-cGMP (Bt 2 cGMP) and dibutyryl-cAMP (Bt 2 cAMP) were purchased from Seikagaku America (Rockville, MD). Actinomycin D and glutathione (GSH) were obtained from Sigma-Aldrich (St. Louis, MO). S-nitrosoglutathione (SNOG) and p38 MAPK inhibitor SB202190 were obtained from Calbiochem (San Diego, CA).
THP-1 cells, a human monocytic line, were obtained from the American Type Culture Collection (Manassas, VA). For all experiments, cells were cultured at 37°C in a 5% CO 2 atmosphere using RPMI-1640 complete medium (BioWhittaker, Walkersville, MD) containing 10% fetal calf serum (FCS; Cellgro, Herndon, VA), 100 U/ml penicillin, 100 g/ml streptomycin, 25 g/ml amphotericin B (all from Cellgro), and 50 M ␤-mercaptoethanol (Sigma-Aldrich).
Human primary monocytes obtained from healthy donors by standard leukapheresis were purified by counterflow centrifugation (elutriation), which yields cells that are 93-95% pure and Ͼ98% viable (Department of Transfusion Medicine, Section of Blood Services and Cell Processing, Clinical Center, National Institutes of Health, Bethesda, MD). Monocytes (1ϫ10 7 ) were cultured at 37°C with 5% CO 2 in 10 ml RPMI-1640 complete medium in which 10% autoplasma was substituted for 10% FCS. For Bt 2 cGMP, Bt 2 cAMP, LPS, SNOG, GSH, and SB202190, the maximum concentrations examined in THP-1 cells or human monocytes did not alter cell viability as determined by trypan blue exclusion.
Cytokine assay
THP-1 cells (5ϫ10 5 /ml/well) were placed in 24-well plates containing RPMI-1640 complete medium with Bt 2 cGMP (0 -50 M) or Bt 2 cAMP (0 -50 M) in combination with LPS (1 g/ml) and SNOG (0 -500 M). GSH, the precursor of SNOG, was used to adjust combined SNOG and GSH concentrations to 500 M in all wells. SNOG (400 M) in RPMI-1640 complete medium produced peak NO⅐ concentrations of ϳ150 M at 1 h, which decayed rapidly to levels of ϳ50 M (NO⅐ Analyzer 280, Sievers, Watertown, MA). After 20 h incubation, culture supernatants were collected. IL-8 and TNF-␣ production was measured using an enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, Minneapolis, MN) according to the manufacturer's instructions. To examine the effect of p38 MAPK on IL-8 production, THP-1 cells were pretreated with the specific p38 MAPK inhibitor SB202190 (0 -0.1 M) for 1 h and then incubated in complete medium for an additional 8 h with LPS (1 g/ml) and phosphate-buffered saline (PBS) alone, GSH (400 M), or SNOG (400 M). IL-8 concentrations in supernatant were then determined as described above.
Quantitation of cytokine mRNA levels and stability
Total RNA from 1 ϫ 10 7 THP-1 cells or primary monocytes was isolated using RNeasy kits (Qiagen, Valencia, CA) after incubation in medium with various treatments and time-periods as specified in the corresponding figures. IL-8, TNF-␣, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) or ␤-actin mRNA levels were measured from 1 to 2 g total RNA using Quantikine colorimetric mRNA quantitation kits and specific Quantikine mRNA probes (R&D Systems) following the manufacturer's instructions. All data were normalized to the housekeeping genes GAPDH or ␤-actin as indicated and expressed in amol/g total RNA using a standard curve.
In one experiment, IL-8 mRNA was measured in THP-1 cells that were pretreated with the p38 MAPK inhibitor SB202190 (0 -0.1 M) for 1 h followed by LPS (1 g/ml) stimulation and exposure to PBS, GSH (400 M), or SNOG (400 M) for 4 h. For measurement of mRNA stability, THP-1 cells or primary monocytes (1ϫ10 7 ) were stimulated with LPS (1 g/ml) for 4 h, followed by 30 min pretreatment with actinomycin D (2.5 g/ml). In two experiments measuring mRNA stability, as indicated, pretreatment also included exposure of some cells to SB202190 (0.1 M). Then PBS, GSH (400 M), or SNOG (400 M) was added, followed by further incubation for 0, 1, 2, or 4 h. Total RNA was prepared, and mRNA was measured as above.
Nuclear run-on assay THP-1 cells (2ϫ10 7 ) were incubated in RPMI-1640 complete medium to which PBS or LPS (1 g/ml) in combination with GSH (400 M) or SNOG (400 M) had been added for 2 h. Nuclei were isolated using nuclei isolation kits (Sigma-Aldrich). Nuclear run-on assay was performed according to the method of Eick and Bornkamm [52] with some modifications. Briefly, nuclei were incubated in reaction buffer [5 mM Tris-CI, pH 8.0, 5.5 mM MgCI 2 , 150 mM KCI, 0.25 mM each adenosine-, cytidine-, and guanosine 5Ј-triphosphate, and 250 Ci ␣-32 P uridine 5Ј-triphosphate (UTP)] for 30 min at 30°C. RNA was isolated using RNeasy mini kits (Qiagen). Equal amounts of labeled RNA, in 5 ml PerfectHyb tm plus hybridization buffer (Sigma-Aldrich), were then hybridized to target DNA immobilized on nitrocellulose filters. After overnight hybridization at 65°C, filters were washed with 2ϫ saline sodium citrate (SSC) containing 0.1% sodium dodecyl sulfate (SDS; 15 min, four times) and then with 0.1ϫ SSC containing 0.1% SDS (30 min, twice). Filters were exposed to X-ray film, and bands were quantitated by densitometry. Results were normalized to the housekeeping gene ␤-actin and expressed as relative fold change.
Plasmid construction
A two-plasmid reporter gene system [37, 38, 53] was constructed for analyzing IL-8 promoter activity. The first plasmid was made from plasmid pTet-off (BD Biosciences, Palo Alto, CA), designated here as pCMV-tTA which uses the strong, immediate cytomegalovirus (CMV) promoter to express the tetracycline (tet)-responsive transcriptional activator (tTA). tTA is a fusion protein, which transactivates expression of a reporter gene, chloramphenicol acetyltransferase (CAT), by binding to a tet-responsive element in the promoter of a second plasmid, pUHG10.3CAT. Promoterless ptTA vector was generated from pCMV-tTA by removing the whole CMV promoter region with XhoI/EcoRI. The human IL-8 promoter (nt -1470 -ϩ40) was inserted into the XhoI/EcoRI site of ptTA, generating p(IL-8)tTA.
Cell transfection and CAT assay
THP-1 cells (3ϫ10 6 ) in 4 ml fresh RPMI-1640 complete medium were planted into six-well plates and cultured for at least 1 h before transfection. Plasmid containing the IL-8 promoter, p(IL-8)tTA, or promoterless plasmid was cotransfected with pUHG10.3CAT and a plasmid containing the simian virus 40 early promoter and ␤-galactosidase reporter (pSV␤-gal; 0.5 g, 0.3 g, 0.1 g /well, respectively) using Effectene transfection kits (Qiagen). After 5 h, cells were washed three times with PBS, recovered for 5 h in fresh medium, and pretreated without or with LPS (1 g/ml) for 30 min, followed by 16 h incubation in the presence of PBS, GSH (400 M), or SNOG (400 M). CAT concentration was measured using ELISA kits (Roche Applied Science, Indianapolis, IN) and normalized to ␤-gal. Promoter activity was expressed as fold induction of CAT compared with p(IL-8)tTA transfection without LPS pretreatment.
Western blotting
Effect of NO⅐ on p38 MAPK phosphorylation in LPS-stimulated THP-1 cells was determined by Western blot. THP-1 cells (5ϫ10 6 ) were preincubated with LPS (1 g/ml) for 90 min, followed by treatment for 30 min with SNOG (0 -400 M). Cells were lysed with ice-cold lysis buffer containing 50 mM HEPES, 5 mM EDTA, 50 mM NaCl, 1% Triton X-100, and protease inhibitor cocktail (Roche Applied Science). Solubilized proteins were collected after centrifugation at 10,000 g in a microcentrifuge at 4°C for 10 min and were then quantitated by bicinchoninic acid assay (Pierce, Rockford, IL). Proteins (20 g) were then separated on 4 -20% Tris-glycine gels and transferred to nitrocellulose membranes (Invitrogen, Carlsbad, CA). The membranes were blocked overnight with Tris-buffered saline containing 5% nonfat dry milk and 0.05% Tween 20 at 4°C and were incubated for 1 h with primary, antiactive p38 MAPK (Promega, Madison, WI) or anti-p38 MAPK antibody (New England Biolabs, Beverly, MA). After incubation with secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA), phosphorylated and nonphosphorylated forms of p38 MAPK were detected by enhanced chemiluminescence (ECL). Results were quantitated using laser densitometry and expressed as relative change compared with control.
Statistical analysis
Data are presented as means Ϯ SEM of at least three independent experiments. All P values are two-sided and considered significant if less than 0.05. Effects of cGMP and cAMP on NO⅐ induction of IL-8 and TNF-␣ production were analyzed by reducing each NO⅐ dose-response curve to the least-squares estimate of their slope using the log of IL-8 or TNF-␣ concentration versus dose. Then, a blocked, exact, nonparametric test for trend was performed across the three ordered cGMP and cAMP doses. To determine the similarity of IL-8 and TNF-␣ responses to cGMP, a three-way ANOVA was used to test for an interaction. For cAMP, the blocked, exact, nonparametric test for trend returned very strong evidence for a dose-related cAMP effect on TNF-␣, but not IL-8, making testing for an interaction unnecessary.
IL-8 and TNF-␣ mRNA levels over time were analyzed using a repeated measures ANOVA followed by post-hoc tests, adjusted for multiple comparisons using the Bonferroni approach to determine which groups were different. Nuclear run-on and reporter gene results were compared using simple paired t-tests, as only two conditions, GSH and SNOG, were of interest. However, the reporter gene data were also analyzed using a three-way ANOVA to assess the effect of LPS in the experiment. Curves measuring mRNA stability were first converted to their respective area under the curve and then compared using a two-factor ANOVA. If this overall test showed that the groups were different, post-hoc tests using the Bonferroni approach were computed for group-wise comparisons.
NO⅐ activation of p38 MAPK was examined using a two-way ANOVA. The effect of increasing doses of p38 MAPK inhibitor on IL-8 expression was assessed by computing the slope of the dose-response curves after log transformation of dose. Slopes were then compared using two-way ANOVA followed by Bonferroni inequality adjusted post-hoc testing. An identical approach was used to analyze the effect of p38 MAPK inhibitor on IL-8 mRNA degradation.
RESULTS
Effect of NO⅐ and cyclic nucleotide analogs on IL-8 and TNF-␣ production NO⅐ dose-dependently increased IL-8 (Pϭ0.008) and TNF-␣ (Pϭ0.002) production in LPS-stimulated THP-1 cells (Figs. 1   Fig. 1 . NO⅐ up-regulation of IL-8 and TNF-␣ is cGMP-independent. THP-1 cells were stimulated with LPS (1 g/ml). At the same time, Bt 2 cGMP (0 -50 M), a cell-permeable cGMP analog, and SNOG (0 -500 M), a NO⅐ donor, were added to the cell cultures. Cells exposed to less then 500 M SNOG were supplemented so that all conditions contained the same concentration of GSH (i.e., 500 M). IL-8 (A) and TNF-␣ (B) released into the medium were measured by ELISA after 20 h of incubation. Data are presented as the means Ϯ SEM of three independent experiments, each run in duplicate. and 2). Increasing concentrations (up to 50 M) of cGMP analog, Bt 2 cGMP, failed to independently increase IL-8 ( Fig.  1A ; Pϭ0.54) production but appeared to have a small but nonsignificant effect on TNF-␣ ( Fig. 1B; Pϭ0.08) . Further, Bt 2 cGMP nonsignificantly augmented NO⅐-induced IL-8 (Pϭ0.07) and TNF-␣ (Pϭ0.18) production. Examining results across the two cytokines, no evidence was found for a difference in the effect of cGMP analog on IL-8 and TNF-␣ (Pϭ0.93). These experiments suggest that NO⅐ regulation of IL-8 and TNF-␣ in LPS-stimulated THP-1 cells occurs primarily through cGMP-independent signal-transduction pathways. This finding is consistent with previous investigations in other cell types including neutrophils for IL-8 [22] and neutrophils [7] , peripheral blood mononuclear cells [6] , and differentiated U937 cells [35, 36] for TNF-␣.
Next, NO⅐ effects on IL-8 and TNF-␣ production were tested for interactions with cAMP. We have previously demonstrated that NO⅐ up-regulates TNF-␣ by decreasing intracellular cAMP in differentiated U937 cells [36] . It is important that in these cells, NO⅐ up-regulation of TNF-␣ is blocked by Bt 2 cAMP [36 -38] , a cell-permeable cAMP analog. However, in LPS-stimulated THP-1 cells, the dose-dependent effect of NO⅐ on IL-8 production was unaffected by Bt 2 cAMP ( Fig. 2A ; Pϭ0.18). Conversely and consistent with its effects in U937 cells, Bt 2 cAMP dose-dependently suppressed NO⅐-induced TNF-␣ production ( Fig. 2B ; Pϭ0.009). These results suggest that NO⅐ regulation of IL-8 is cGMP-and cAMP-independent, and TNF-␣ is cGMP-independent but cAMP-dependent. The findings support the notion that NO⅐ regulates these two cytokines through distinct signal-transduction pathways.
Effect of NO⅐ on IL-8 and TNF-␣ mRNA expression
To examine whether NO⅐ regulates IL-8 and TNF-␣ mRNA expression, THP-1 cells were incubated with PBS, GSH (400 M), or SNOG (400 M) for 2, 4, and 6 h in the presence of LPS (1 g/ml). As shown in Figure 3A , the NO⅐ donor SNOG significantly increased LPS-induced IL-8 mRNA levels, with a peak effect at 4 h, compared with GSH or PBS (adjusted Pϭ0.004 for both comparisons). Similar to our previous findings in differentiated U937 cells [36] , NO⅐ increased TNF-␣ mRNA in LPS-stimulated THP-1 cells ( Fig. 3B; adjusted   Fig. 2 . NO⅐ up-regulation of IL-8 but not TNF-␣ is cAMP-independent. THP-1 cells were stimulated with LPS (1 g/ml). At the same time, Bt 2 cAMP (0 -50 M), a cell-permeable cAMP analog, and SNOG (0 -500 M), a NO⅐ donor, were added to the cell cultures. Cells exposed to less than 500 M SNOG were supplemented so that all conditions contained the same concentration of GSH (i.e., 500 M). IL-8 (A) and TNF-␣ (B) released into the medium were measured by ELISA after 20 h of incubation. Data are presented as the means Ϯ SEM of three independent experiments, each run in duplicate. Fig. 3 . Effect of NO⅐ on IL-8 and TNF-␣ mRNA levels. THP-1 cells were stimulated with LPS (1 g/ml) and incubated with PBS, GSH (400 M), or SNOG (400 M). Cells were harvested for total RNA preparation at the indicated time-points. IL-8 (A) and TNF-␣ (B) mRNA levels were quantitated using a colorimetric assay normalized to GAPDH mRNA levels. Results are expressed relative to 1 g total RNA and presented as the means Ϯ SEM of three independent experiments. PՅ0.037 compared with GSH or PBS). Peak mRNA levels appeared to occur earlier (at 2 h) and decay faster for TNF-␣ compared with IL-8.
Effect of NO⅐ on IL-8 and TNF-␣ transcription
Changes in promoter activity or transcript stability or both can alter mRNA levels. NO⅐ has been demonstrated to induce TNF-␣ gene transcription in differentiated U937 cells by decreasing intracellular levels of cAMP [36] , thereby reducing promoter repression at a proximal GC-box element [37, 38] . However, the IL-8 promoter lacks a similar GC-box element [42] . Further, in LPS-stimulated THP-1 cells, cAMP analog blocked NO⅐ induction of TNF-␣ but not IL-8 (Fig. 2) . Therefore, we next determined whether NO⅐ transcriptionally regulates IL-8 or TNF-␣ in LPS-stimulated THP-1 cells. As determined with nuclear run-on assays (Fig. 4) , NO⅐ did not increase and tended to slightly decrease IL-8 transcription in LPS-stimulated THP-1 cells (Pϭ0.08, comparing SNOG with GSH). In contrast and as expected from previous results in U937 cells [37, 38] , NO⅐ significantly increased TNF-␣ transcription (Pϭ0.012) in LPS-stimulated THP-1 cells (Fig. 4) .
Effect of NO⅐ on IL-8 promoter activity
To further confirm the above result that NO⅐ does not increase IL-8 transcription, IL-8 promoter activity was examined using a two-plasmid CAT reporter gene assay (Fig. 5) . LPS stimulation was found to significantly activate the IL-8 promoter (2.9-fold compared with PBS; Pϭ0.0001 for an LPS effect across all conditions). However, in the absence (Pϭ0.43) or presence (Pϭ0.84) of LPS, NO⅐ had no effect on IL-8 promoter activity in LPS-stimulated THP-1 cells (Fig. 5) .
Effect of NO⅐ on IL-8 and TNF-␣ mRNA stability in THP-1 cells
Finding that NO⅐ up-regulated IL-8 protein and mRNA expression but did not increase IL-8 mRNA transcription, we next investigated whether NO⅐ affected IL-8 mRNA transcript stability. THP-1 cells were treated with LPS to induce IL-8 and TNF-␣ mRNA expression. Transcription was then blocked with actinomycin D, and the half-lives of IL-8 and TNF-␣ transcripts were assessed. IL-8 and TNF-␣ are known to undergo substantial post-transcriptional regulation. Although NO⅐ has been shown here and previously [35] [36] [37] [38] to regulate TNF-␣ transcription, its effects on TNF-␣ mRNA stability have not been reported. As shown in Figure 6A , the NO⅐ donor SNOG significantly protected IL-8 mRNA from degradation (Pϭ0.001) compared with PBS or GSH, which produced nearly identical decay curves (Pϭ1.00). NO⅐ increased the half-life of IL-8 mRNA to more than 4 h compared with 1-1.5 h for GSH (Fig. 6A) . In contrast, TNF-␣ degradation was unaffected across the three treatments ( Fig. 6B ; Pϭ0.63).
Role of p38 MAPK in NO⅐ regulation of IL-8 expression and mRNA stabilization in THP-1 cells
We previously demonstrated that NO⅐ activates p38 MAPK in phorbol ester-differentiated U937 cells [51] . Further, p38 MAPK activation has been reported to stabilize various mRNA transcripts, including IL-8 [47] [48] [49] . Here, we first determined 2ϫ10 7 ) were stimulated with LPS (1 g/ml) and incubated with GSH (400 M) or SNOG (400 M) for 2 h. Unstimulated cells not exposed to LPS (PBS only) were examined concurrently for comparison. Nuclei were isolated and incubated in reaction buffer containing ␣-P 32 UTP. RNA was then isolated and hybridized to target DNA immobilized on nitrocellulose filters. Bands on X-ray film exposed to the filters were quantitated by densitometry. A representative experiment (A) and densitometry results (B) expressed as ratios to concurrently run ␤-actin controls are shown. Data presented are the means Ϯ SEM of four independent experiments. whether NO⅐ activates p38 MAPK in LPS-stimulated THP-1 cells. In Figure 7A , a representative Western blot shows that phosphorylated (activated) p38 MAPK rises in cells exposed to increasing concentrations of the NO⅐ donor SNOG. The densitometry results from these experiments demonstrate that NO⅐ dose-dependently increased the phosphorylation of p38 MAPK in LPS-stimulated THP-1 cells (Fig. 7B ; Pϭ0.0001), and total quantities of p38 MAPK remained unchanged (Pϭ0.51). Similar results were also observed in human primary monocytes (data not shown).
Next, we examined the effect of a p38 MAPK inhibitor, SB202190, on IL-8 protein (Fig. 8A) and IL-8 mRNA (Fig.  8B ) levels in LPS-stimulated THP-1 cells after 8 and 4 h of incubation, respectively. Notably, although small doses of SB202190 decreased IL-8 protein and mRNA levels under all conditions, its effects were significantly larger in the presence of the NO⅐ donor SNOG compared with GSH (Pϭ0.013 for IL-8 protein; Pϭ0.039 for IL-8 mRNA). This result supports the notion that NO⅐ induction of IL-8 is influenced by p38 MAPK activation.
Finally, the role of p38 MAPK activation in NO⅐-induced IL-8 mRNA stabilization was explored (Fig. 9) . Again, the NO⅐ donor SNOG was shown to significantly stabilize IL-8 mRNA (PϽ0.01). Furthermore, the p38 MAPK inhibitor SB202190 significantly increased IL-8 mRNA degradation in the presence of NO⅐ (PϽ0.018) but not in the presence of GSH alone (Pϭ1.00).
Effects of NO⅐ and p38 MAPK inhibition on IL-8 and TNF-␣ mRNA stability in human primary monocytes
To examine the relevance of the above results obtained with THP-1 cells, we further investigated the effects of NO⅐ and p38 MAPK inhibition on IL-8 and TNF-␣ mRNA stabilization in human primary monocytes. As shown in Figure 10A , NO⅐ donor SNOG significantly increased IL-8 mRNA stability compared with the GSH control condition (Pϭ0.001). This effect of NO⅐ was completely blocked by the specific p38 MAPK inhibitor SB202190 (Pϭ0.001), which did not affect the IL-8 mRNA decay curve of the GSH control ( Fig. 10A; Pϭ1.0, adjusted) . In contrast to IL-8, TNF-␣ mRNA stability was not altered by NO⅐; SNOG and GSH resulted in similar decay curves ( Fig.  10B; Pϭ0.32) . Furthermore, the p38 MAPK inhibitor SB202190 had no effect on TNF-␣ mRNA degradation in the presence of SNOG or GSH ( Fig. 10B; Pϭ0.32 ). 1ϫ10 7 ) were stimulated with LPS (1 g/ml) for 4 h at 37°C to induce IL-8 and TNF-␣. After 30 min pretreatment with actinomycin D (2.5 g/ml), cells were further incubated with PBS, GSH (400 M), or SNOG (400 M) for 0 -4 h. Cells were then harvested, and total RNA was prepared. IL-8 (A) and TNF-␣ (B) mRNA was quantitated using a colorimetric assay normalized to GAPDH mRNA levels. Results are expressed relative to mRNA levels at 0 h, which were arbitrarily set to 100%. Data presented are the means Ϯ SEM of five independent experiments. Fig. 7 . NO⅐ activates p38 MAPK. THP-cells (5ϫ10 6 ) were incubated in medium alone or medium with LPS (1 g/ml) for 90 min at 37°C. SNOG (0 -400 M) was then added for an additional 30 min, and the cells were lysed for Western blotting. Nonphosphorylated (pp38) and phosphorylated forms (p38) of p38 MAPK were detected by specific antibody and ECL. Results were quantitated with laser densitometry and expressed as ratios relative to control values (SNOGϭ0 M). Data presented are the means Ϯ SEM of three independent experiments.
DISCUSSION
Soluble guanylate cyclase activation and subsequent increases in intracellular cGMP are closely associated with many biological activities of NO⅐ [10, 11, 13] . However, cGMP-independent pathways appear to play an important role in NO⅐ regulation of gene expression [5-9, 22, 35-38, 54 -57] . Our present study in LPS-stimulated THP-1 cells demonstrates that NO⅐ up-regulates IL-8 and TNF-␣, independent of cGMP. Up to 50 M Bt 2 cGMP had only modest effects on IL-8 or TNF-␣, suggesting that cGMP was not an essential second messenger in NO⅐ up-regulation of these cytokines. This is in accordance with previous findings that NO⅐ increases the production of IL-8 and TNF-␣ in a variety of cell types [6, 7, 22, 35, 36] through cGMP-independent mechanisms.
TNF-␣ promoter activity is inhibited by cAMP via activation of cAMP-dependent protein kinase and the subsequent phosphorylation of transcriptional factors [43, 53, 58] . We previously demonstrated that NO⅐ increases TNF-␣ gene transcription in phorbol ester-differentiated U937 cells by decreasing intracellular cAMP concentrations [36] . Further investigation identified a proximal GC box in the TNF-␣ promoter that transduces NO⅐/cAMP/cAMP-dependent protein kinase signaling [37, 38] . NO⅐ enhances TNF-␣ promoter activity by inhibiting the binding of trans-repressor Sp proteins to this GC box [38] . Consistent with these results, the present study showed in LPS-stimulated THP-1 cells that Bt 2 cAMP, a cell-permeable cAMP analog, attenuated NO⅐-induced TNF-␣ production. Further, nuclear run-on assay, like previous reporter gene experiments in U937 cells [37, 38] , demonstrated that TNF-␣ gene transcription was up-regulated by NO⅐ in LPS-stimulated THP-1 cells. In contrast, the up-regulatory effect of NO⅐ on IL-8 was not altered by Bt 2 cAMP. Moreover, NO⅐ did not increase the transcription of IL-8 as measured by nuclear run-on assay and reporter gene analysis. Accordingly, DNA foot-printing in THP-1 cells demonstrated that NO⅐, in the concentrations examined here, had little or no effect on protein binding to the activated protein 1 (AP-1), nuclear factor (NF)-IL-6, NF-B, and Oct-1 sites in the IL-8 proximal promoter (data not shown). Finally, we demonstrated that NO⅐ regulates IL-8 mRNA half-life in THP-1 cells and human primary monoctyes. This effect is at least partially dependent on p38 MAPK activation. Collectively, these results show that NO⅐ regulates TNF-␣ and IL-8 by distinct cGMP-independent mechanisms.
In contrast to our results, other studies have shown that NO⅐ regulates IL-8 at the level of transcription [39 -41, 55-57] . Most frequently, NO⅐ has been observed or suggested to increase rather than decrease IL-8 promoter activity or transcription. Work reporting this result has been conducted in a wide 1ϫ10 7 ) were harvested after 4 h of incubation for total RNA preparation. IL-8 mRNA (B) was quantitated using a colorimetric assay normalized to GAPDH mRNA levels, and results are expressed relative to 1 g total RNA. Data presented are the means Ϯ SEM of five independent experiments. 1ϫ10 7 ) were stimulated with LPS (1 g/ml) for 4 h to induce IL-8. After 30 min pretreatment with actinomycin D (2.5 g/ml) without and with SB202190 (0.1 M), cells were further incubated with PBS, GSH (400 M), or SNOG (400 M) for 0 -4 h. At the specified time-points, cells were harvested for total RNA preparation. IL-8 mRNA was then quantitated using a colorimetric assay normalized to GAPDH mRNA levels. Results are expressed relative to mRNA levels at 0 h, which were arbitrarily set to 100%. Data presented are the means Ϯ SEM of three independent experiments. variety of cell types including melanocytes [39] , keratinocytes [40] , U937 cells [24] , and pancreatic adenocarcinoma. Conversely, down-regulation of promoter activity has also been seen, particularly in endothelial cells [55, 56] . However, another group of investigators has reported that NO⅐ increases the release of IL-8 protein in the same endothelial cell line [59] . Although these studies demonstrate, in some systems and cell types, that changes in transcription can play an important role in NO⅐ regulation of IL-8, the possibility of substantial posttranscriptional effects was not investigated. Closest to our findings, Xiong et al. [41] showed in human pancreatic adenocarcinoma cells that NO⅐ stabilized IL-8 mRNA in addition to up-regulating its transcription. Possible mechanisms responsible for mRNA stabilization were not investigated. Our results in LPS-stimulated THP-1 cells and human monocytes suggest that post-transcriptional stabilization of mRNA may be the predominant mechanism by which NO⅐ regulates IL-8. Furthermore, p38 MAPK signaling was identified as a major downstream pathway responsible for this effect of NO⅐.
To date, NO⅐ regulation of IL-8 and other genes has been attributed to a broad range of possible mechanisms. However, most of these appear to have little impact on the system we investigated. A number of IL-8 promoter elements such as AP-1, NF-IL-6, NF-B, and Oct-1-binding sites [42] [43] [44] have been experimentally associated with NO⅐ regulation of gene expression [6, 8, 10, 11, 39, 54 -57] . For example, AP-1 can be activated by NO⅐ through the second messenger cGMP and thereby regulate transcription [10, 11] . Although most studies, like ours, have found that IL-8 regulation by NO⅐ is cGMPindependent, one report in a mesangial cell line came to the opposite conclusion [60] . This result and well-documented examples of IL-8 promoter activation by AP-1 [44, 48, 61] suggest that the NO⅐/cGMP/AP-1 signaling pathway is likely to be an important transducer of NO⅐ effects on IL-8 under some conditions. A contrasting report in an endothelial cell line found that NO⅐ suppressed IL-8 transcription by blocking C-Jun N-terminal kinase-induced AP-1 activation [56] . Likewise, it has been shown that NO⅐ can variably activate or inactivate NF-B signal transduction through several mechanisms [6, 8, 54, 55, 62, 63] . Although our results clearly rule out NO⅐ activation of the IL-8 promoter in LPS-stimulated THP-1 cells under other circumstances, NO⅐ effects at these promoter sites might be substantial, as transcriptional regulation is highly context-dependent.
The specificity of post-transcriptional regulation and its overall important contribution to gene expression have been increasingly recognized [64 -67] . IL-8 and TNF-␣ mRNAs have ARE in their 3Ј-UTR and have been shown to undergo substantial regulation after transcription [45] [46] [47] [48] [49] [50] . However, as shown here, the mRNA of IL-8 but not TNF-␣ was significantly stabilized by NO⅐ through a p38 MAPK-dependent signaltransduction pathway. The 3Ј-UTR of TNF-␣ tightly controls its degradation and translation [49, 50, 68] . Knockout mice with TNF-␣ mRNA lacking a 3Ј-UTR are unable to appropriately turn off TNF-␣ and develop an autoimmune illness phenotype [68] . Notably, Brook et al. [69] demonstrated in a mouse macrophage cell line that TNF-␣ mRNA was stabilized by p38 MAPK. In contrast, here, we found that TNF-␣ mRNA half-life was not affected by NO⅐, despite p38 MAPK activation. Our results agree with a recent experiment, also conducted in LPS-stimulated THP-1 cells, showing that the post-transcriptional regulation of IL-8 but not TNF-␣ was p38 MAPKdependent [49] . However, compared with IL-8, TNF-␣ mRNA half-life is shorter, suggesting that these two cytokines have different mRNA decay kinetics. Therefore, we cannot exclude the possibility that NO⅐ may affect TNF-␣ mRNA degradation at time-points earlier than 1 h. The 3Ј-UTR of IL-8 has multiple ARE [46] . At least two of these, located between nucleotides 972 and 1132, have been associated with p38 MAPK-mediated stabilization of IL-8 mRNA. It is interesting that fewer than 10% of known ARE-containing genes appear to be post-transcriptionally regulated by p38 MAPK [49] .
In summary, the current investigation has identified a cGMP-independent mechanism, distinct from that for TNF-␣, Fig. 10 . Effects of NO⅐ and p38 MAPK inhibition on IL-8 and TNF-␣ mRNA stabilization in human primary monocytes. Elutriated monocytes (1ϫ10 7 ) were stimulated with LPS (1 g/ml) for 4 h to induce cytokines. After 30 min pretreatment with actinomycin D (2.5 g/ml) without and with SB202190 (0.1 M), cells were further incubated with GSH (400 M) or SNOG (400 M) for 0 -4 h. At the specific time-points, cells were harvested for total RNA extraction. IL-8 (A) and TNF-␣ (B) mRNA was then quantitated using a colorimetric assay normalized to ␤-actin mRNA levels. Results are expressed relative to mRNA levels at 0 h, which were arbitrarily set to 100%. Data presented are the means Ϯ SEM of four independent experiments.
by which NO⅐ regulates IL-8. NO⅐ substantially stabilizes IL-8 mRNA through a pathway that is dependent on its ability to activate p38 MAPK. The overall importance of this pathway in the regulation of inflammation and leukocyte migration by NO⅐ remains to be determined. However, recent reports indicate that these immune-modulatory effects function in vivo [25, 26] . Shanley et al. [25] and Okamoto et al. [26] found that the lungs of iNOS knockout mice compared with wild-type animals had reduced proinflammatory cytokine production and neutrophil accumulation in response to LPS challenge. These studies strongly support the concept that iNOS induction contributes to the appropriate trafficking of neutrophils to sites of inflammation. It is interesting that immunologic and gene-regulatory effects of NO⅐ appear to be compartmentalized geographically and mechanistically. For example, NO⅐ inhibition of neutrophil adhesion and induction of TNF-␣ and IL-8 all occur through different pathways. This may permit cross-talk and also maintain the potential for the differential regulation of these dissimilar responses in the microenvironment of the vessel wall. Therefore, NO⅐-mediated modulation of immunity might be, to some degree, therapeutically dissectible. Interventions may be possible that allow certain pathways to proceed unabated, even as others are selectively blocked.
